Home » Stocks » ITMR

Itamar Medical Ltd. (ITMR)

Stock Price: $25.23 USD -0.27 (-1.06%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
Market Cap 361.79M
Revenue (ttm) 31.26M
Net Income (ttm) -5.27M
Shares Out 287.62M
EPS (ttm) -0.90
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $25.23
Previous Close $25.50
Change ($) -0.27
Change (%) -1.06%
Day's Open 25.35
Day's Range 24.94 - 25.49
Day's Volume 16,732
52-Week Range 7.95 - 29.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

CAESAREA, Israel, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea m...

GlobeNewsWire - 1 week ago

CAESAREA, Israel, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea m...

GlobeNewsWire - 1 month ago

Positive Coverage Policy from Health Care Service Corporation (HCSC) Covers Blue Cross Blue Shield Members in Illinois, Montana, New Mexico, Oklahoma and Texas Positive Coverage Policy from He...

GlobeNewsWire - 1 month ago

WatchPAT™ to effectively maintain current reimbursement levels despite broader reduction in conversion rates WatchPAT™ to effectively maintain current reimbursement levels despite broader redu...

GlobeNewsWire - 1 month ago

Results Further Support Use of WatchPAT for Home-Based Sleep Apnea Testing as an Effective Alternative to In-Lab PSG Testing Results Further Support Use of WatchPAT for Home-Based Sleep Apnea ...

GlobeNewsWire - 2 months ago

CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercializatio...

Seeking Alpha - 2 months ago

Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 2 months ago

Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for sleep apnea Initial findings show potential for material shor...

GlobeNewsWire - 2 months ago

- Third Quarter Revenues Increase 36 % to $ 11.0 Million -

GlobeNewsWire - 2 months ago

CAESAREA, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasi...

GlobeNewsWire - 3 months ago

CAESAREA, Israel, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and...

GlobeNewsWire - 3 months ago

Q3 Total Revenue Results of $10.7 M to $ 11 . 0 M , reflecting growth of 32 %- 36 %

GlobeNewsWire - 3 months ago

CAESAREA, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and...

GlobeNewsWire - 4 months ago

Updated guidelines represent a significant milestone in the adoption of Itamar’s Peripheral Arterial Tonometry (PAT) based Home Sleep Apnea Testing (HSAT) in Europe, following adoption in the ...

GlobeNewsWire - 4 months ago

CAESAREA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercializa...

GlobeNewsWire - 4 months ago

CAESAREA, Israel, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercializat...

GlobeNewsWire - 4 months ago

As a platinum sponsor, Itamar Medical’s virtual booth and on-demand content to be offered to SLEEP 2020 attendees As a platinum sponsor, Itamar Medical’s virtual booth and on-demand content to...

Seeking Alpha - 5 months ago

Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Itamar Medical Ltd. Sponsored ADR (ITMR) delivered earnings and revenue surprises of 10.53% and 12.18%, respectively, for the quarter ended June 2020.

Zacks Investment Research - 5 months ago

Itamar Medical Ltd. Sponsored ADR (ITMR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

GlobeNewsWire - 5 months ago

CAESAREA, Israel, July 27, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-inva...

Zacks Investment Research - 6 months ago

Itamar Medical (ITMR) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Zacks Investment Research - 6 months ago

Itamar Medical Ltd. Sponsored ADR (ITMR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Investment Research - 7 months ago

As of late, it has definitely been a great time to be an investor in Itamar Medical.

GlobeNewsWire - 7 months ago

- First Quarter 2020 Revenues Increase 38% to $8.4 Million -

GlobeNewsWire - 8 months ago

Complete, home-based solution for diagnosing respiratory sleep disorders approved for commercialization in Europe and other CE Mark geographies Complete, home-based solution for diagnosing res...

GlobeNewsWire - 8 months ago

Study conducted at Mount Sinai Hospital in New York City designed to demonstrate benefit of continuous positive airway pressure (CPAP) in delaying or eliminating hospitalization and/or ventila...

GlobeNewsWire - 9 months ago

- Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests -

GlobeNewsWire - 9 months ago

Streamlining the complex process from sleep apnea diagnosis to treatment using digital health platforms meets shared mission of addressing the growing and undermanaged sleep apnea epidemic

GlobeNewsWire - 10 months ago

CAESAREA, Israel, March 20, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq:  ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-in...

GlobeNewsWire - 10 months ago

Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in combination with health medical records can be leveraged to predict cardio...

GlobeNewsWire - 11 months ago

Two additional published studies highlight WatchPAT’s accuracy and effectiveness in patients with Central Sleep Apnea (CSA) and Chronic Obstructive Pulmonary Disease (COPD)

GlobeNewsWire - 11 months ago

CAESAREA, Israel, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-inva...

GlobeNewsWire - 11 months ago

CAESAREA, Israel, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-inva...

GlobeNewsWire - 11 months ago

CAESAREA, Israel, Jan. 28, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-inva...

GlobeNewsWire - 1 year ago

- 2019 Fiscal Year Revenues Expected to Increase 29% to $31.1 Million to $31.3 Million -

GlobeNewsWire - 1 year ago

Selection of Itamar's WatchPAT home sleep apnea diagnostic system underscores the importance and significance of understanding sleep disorders to prevent and manage risk of heart disease and s...

About ITMR

Itamar Medical engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operat... [Read more...]

Industry
Medical Devices
Founded
1997
CEO
Gilad Glick
Employees
184
Stock Exchange
NASDAQ
Ticker Symbol
ITMR
Full Company Profile

Financial Performance

In 2019, Itamar Medical's revenue was $31.26 million, an increase of 29.22% compared to the previous year's $24.19 million. Losses were -$5.27 million, 204.7% more than in 2018.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for Itamar Medical stock is "Strong Buy." The 12-month stock price forecast is 28.66, which is an increase of 13.59% from the latest price.

Price Target
$28.66
(13.59% upside)
Analyst Consensus: Strong Buy